Top compounds associated with response to EIF3C


Feature Type Standardized
Nominal ANOVA
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.012 0.7
mRNA neratinib CTRPv2 pan-cancer AAC -0.011 0.7
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.0099 0.7
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.7
mRNA lapatinib CTRPv2 pan-cancer AAC -0.011 0.7
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.01 0.7
mRNA Doxorubicin gCSI pan-cancer AAC 0.016 0.7
mRNA ouabain CTRPv2 pan-cancer AAC -0.011 0.8
mRNA procarbazine CTRPv2 pan-cancer AAC -0.012 0.8
Download CSV